<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02463929</url>
  </required_header>
  <id_info>
    <org_study_id>UDiponegoro</org_study_id>
    <nct_id>NCT02463929</nct_id>
  </id_info>
  <brief_title>Dyphenhidramine Effect on Prevention of Sevoflurane Induced Post Anesthesia Agitation in Pediatric</brief_title>
  <official_title>Dyphenhidramine Effect on Prevention of Sevoflurane Induced Post Anesthesia Agitation in Pediatric</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitas Diponegoro</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Permata Sari Hospital for Plastic Surgery</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Universitas Diponegoro</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate the effect of diphenhydramine on the prevention
      of sevoflurane induced emergence delirium/ agitation in pediatrics. The Investigators
      hypothesis is that it reduce the incidence of sevoflurane induced emergence delirium/
      agitation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is an experimental clinical trial in double-blinded randomized controlled design on 50
      children aged 10 months to 21 months who underwent general anesthesia with sevoflurane for
      labioplasty surgery. Fifteen minutes before inhalation anesthetics were discontinued, the
      subjects were randomly given a placebo or a single dose of diphenhydramine 0, 5 mg / kg
      intravenously. Subjects were extubated and observed in the recovered space conscious for any
      agitation or emergence delirium and feasability to return to the ward. Agitation or emergence
      delirium was assessed by the Pediatric Emergence Agitation and Delirium Score (PAEDS) whereas
      feasability to return to the ward scored with the Steward score. When PAEDS&gt; 10 patients were
      assessed to be agitated or having emergence delirium and administeres rescue tranquilizer
      ketamine 0.1 mg / kg. Total rescue tranquilizers and clinically significant adverse effects
      of drugs also recorded.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2014</start_date>
  <completion_date type="Actual">July 2014</completion_date>
  <primary_completion_date type="Actual">June 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of sevoflurane induced post anesthesia agitation</measure>
    <time_frame>10 minutes post extubation</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Amount of rescue Ketamine used</measure>
    <time_frame>1 minute post extubation, at emergence, 15 minute post extubation</time_frame>
    <description>Administration of 0,1 mg/kg ketamine intravenously if the patient gets agitated</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Significant adverse events</measure>
    <time_frame>1 minute post extubation, at emergence, 15 minute post extubation</time_frame>
    <description>Any respiratory or cardiovascular events during observation in recovery room</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Pediatric Emergence Agitation and Delirium Score (PAEDS)</measure>
    <time_frame>1 minute post extubation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Pediatric Emergence Agitation and Delirium Score (PAEDS)</measure>
    <time_frame>at emergence</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Pediatric Emergence Agitation and Delirium Score (PAEDS)</measure>
    <time_frame>15 minute post extubation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of sevoflurane induced post anesthesia agitation</measure>
    <time_frame>1 minute post extubation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of sevoflurane induced post anesthesia agitation</measure>
    <time_frame>15 minute post extubation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of stay in recovery room</measure>
    <time_frame>up to 15 minutes post extubation</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Specified Sedative</condition>
  <condition>Hypnotic</condition>
  <arm_group>
    <arm_group_label>diphenhydramine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subject sedated with sevoflurane, and given bilateral extraoral infraorbital block with 0,125% bupivacaine. Subject injected 0,5mg/kg diphenhydramine intravenously, 15 minutes prior to discontinuation of sevoflurane. If subject develop agitation, 0,1 mg/kg ketamine is administered</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Subject sedated with sevoflurane, and given bilateral extraoral infraorbital block with 0,125% bupivacaine. Subject injected 0,5cc/kg normal saline intravenously, 15 minutes prior to discontinuation of sevoflurane. If subject develop agitation, 0,1 mg/kg ketamine is administered</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Diphenhydramine</intervention_name>
    <description>Intravenous Injection</description>
    <arm_group_label>diphenhydramine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>normal saline</intervention_name>
    <description>Intravenous Injection</description>
    <arm_group_label>control</arm_group_label>
    <other_name>NaCl 0,9%</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ketamine</intervention_name>
    <description>Ketamine 0,1 mg/kg intravenously used as rescue tranquilizer if the subject becomes agitated, repeated dose of 0,05 mg/kg every minute can be given if the agitation does not resolve, maximum ketamine dose for tranquilizer 0,25 mg/kg to prevent deep sedation</description>
    <arm_group_label>diphenhydramine</arm_group_label>
    <arm_group_label>control</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sevoflurane</intervention_name>
    <description>Sevoflurane as single sedation agent for general anesthesia in both arm. 8% Sevoflurane in 100% oxygen used as induction agent, and 2% sevoflurane in 50% oxygen used as maintenance agent</description>
    <arm_group_label>diphenhydramine</arm_group_label>
    <arm_group_label>control</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine</intervention_name>
    <description>Bilateral extraoral infraorbital nerve block with 0,125% Bupivacaine as analgetic for operation and post operation.</description>
    <arm_group_label>diphenhydramine</arm_group_label>
    <arm_group_label>control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        ASA I or 2

          -  no cardiovascular, respiratory or neurologic congenital anomalies

          -  no allergic reactions, or any contraindication to drugs used in this trial ever
             documented

        Exclusion Criteria:

          -  congenital anomalies recognized/diagnosed during trial procedures

          -  hemmorhage &gt; 15% EBV

          -  shock or other major anesthesia or surgical complications during trial procedures
             (hipoxia, atelectasis, unintended disconection of ETT or IV line)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Months</minimum_age>
    <maximum_age>24 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Johan Mr Arifin, dr</last_name>
    <role>Study Director</role>
    <affiliation>Universitas Diponegoro</affiliation>
  </overall_official>
  <reference>
    <citation>Varughese AM, Rampersad SE, Whitney GM, Flick RP, Anton B, Heitmiller ES. Quality and safety in pediatric anesthesia. Anesth Analg. 2013 Dec;117(6):1408-18. doi: 10.1213/ANE.0b013e318294fb4a. Review.</citation>
    <PMID>24257392</PMID>
  </reference>
  <reference>
    <citation>Cohen IT, Finkel JC, Hannallah RS, Hummer KA, Patel KM. The effect of fentanyl on the emergence characteristics after desflurane or sevoflurane anesthesia in children. Anesth Analg. 2002 May;94(5):1178-81, table of contents.</citation>
    <PMID>11973185</PMID>
  </reference>
  <reference>
    <citation>Köner O, Türe H, Mercan A, Menda F, Sözübir S. Effects of hydroxyzine-midazolam premedication on sevoflurane-induced paediatric emergence agitation: a prospective randomised clinical trial. Eur J Anaesthesiol. 2011 Sep;28(9):640-5. doi: 10.1097/EJA.0b013e328344db1a.</citation>
    <PMID>21822077</PMID>
  </reference>
  <reference>
    <citation>Abdallah C, Hannallah R. Premedication of the child undergoing surgery. Middle East J Anaesthesiol. 2011 Jun;21(2):165-74. Review.</citation>
    <PMID>22435268</PMID>
  </reference>
  <reference>
    <citation>Aouad MT, Nasr VG. Emergence agitation in children: an update. Curr Opin Anaesthesiol. 2005 Dec;18(6):614-9.</citation>
    <PMID>16534301</PMID>
  </reference>
  <reference>
    <citation>Simons FE, Simons KJ. Clinical pharmacology of H1-antihistamines. Clin Allergy Immunol. 2002;17:141-78. Review.</citation>
    <PMID>12113216</PMID>
  </reference>
  <verification_date>June 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 18, 2015</study_first_submitted>
  <study_first_submitted_qc>June 2, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 4, 2015</study_first_posted>
  <last_update_submitted>June 2, 2015</last_update_submitted>
  <last_update_submitted_qc>June 2, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 4, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universitas Diponegoro</investigator_affiliation>
    <investigator_full_name>Ika Cahyo Purnomo</investigator_full_name>
    <investigator_title>Doctor</investigator_title>
  </responsible_party>
  <keyword>Diphenhydramine</keyword>
  <keyword>emergence agitation</keyword>
  <keyword>pediatric anesthesia</keyword>
  <keyword>PAEDS</keyword>
  <keyword>Withdrawal</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Psychomotor Agitation</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Ketamine</mesh_term>
    <mesh_term>Sevoflurane</mesh_term>
    <mesh_term>Diphenhydramine</mesh_term>
    <mesh_term>Promethazine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

